 | • レポートコード：MRC2Q12-00982 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、サルタン医薬品APIのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 サルタン医薬品APIのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 サルタン医薬品APIの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 サルタン医薬品APIのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのサルタン医薬品APIの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のサルタン医薬品APIの売上および2028年までの予測に焦点を当てています。 サルタン医薬品APIのグローバル主要企業には、Dr. Reddy’s Laboratories、Verdant Pharma Pvt Ltd、Anuh Pharma Ltd.、Ningbo Menovo Pharmaceutical、Tianyu Pharmaceutical、Zhejiang Huahai Pharmaceutical、Changzhou Kony Pharmaceutical、Zhejiang Kinglyuan Pharmaceutical、Zhejiang Xinsaike Pharmaceutical、Rundu Pharmaなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 サルタン医薬品API市場は、タイプとアプリケーションによって区分されます。世界のサルタン医薬品API市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI 【アプリケーション別セグメント】 錠剤、カプセル剤、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - サルタン医薬品API製品概要 - タイプ別市場（ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI） - アプリケーション別市場（錠剤、カプセル剤、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のサルタン医薬品API販売量予測2017-2028 - 世界のサルタン医薬品API売上予測2017-2028 - サルタン医薬品APIの地域別販売量 - サルタン医薬品APIの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別サルタン医薬品API販売量 - 主要メーカー別サルタン医薬品API売上 - 主要メーカー別サルタン医薬品API価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ロサルタンAPI、バルサルタンAPI、イルベサルタンAPI、オルメサルタンAPI、カンデサルタンAPI、テルミサルタンAPI） - サルタン医薬品APIのタイプ別販売量 - サルタン医薬品APIのタイプ別売上 - サルタン医薬品APIのタイプ別価格 ・アプリケーション別市場規模（錠剤、カプセル剤、その他） - サルタン医薬品APIのアプリケーション別販売量 - サルタン医薬品APIのアプリケーション別売上 - サルタン医薬品APIのアプリケーション別価格 ・北米市場 - 北米のサルタン医薬品API市場規模（タイプ別、アプリケーション別） - 主要国別のサルタン医薬品API市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのサルタン医薬品API市場規模（タイプ別、アプリケーション別） - 主要国別のサルタン医薬品API市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のサルタン医薬品API市場規模（タイプ別、アプリケーション別） - 主要国別のサルタン医薬品API市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のサルタン医薬品API市場規模（タイプ別、アプリケーション別） - 主要国別のサルタン医薬品API市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのサルタン医薬品API市場規模（タイプ別、アプリケーション別） - 主要国別のサルタン医薬品API市場規模（トルコ、サウジアラビア） ・企業情報 Dr. Reddy’s Laboratories、Verdant Pharma Pvt Ltd、Anuh Pharma Ltd.、Ningbo Menovo Pharmaceutical、Tianyu Pharmaceutical、Zhejiang Huahai Pharmaceutical、Changzhou Kony Pharmaceutical、Zhejiang Kinglyuan Pharmaceutical、Zhejiang Xinsaike Pharmaceutical、Rundu Pharma ・産業チェーン及び販売チャネル分析 - サルタン医薬品APIの産業チェーン分析 - サルタン医薬品APIの原材料 - サルタン医薬品APIの生産プロセス - サルタン医薬品APIの販売及びマーケティング - サルタン医薬品APIの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - サルタン医薬品APIの産業動向 - サルタン医薬品APIのマーケットドライバー - サルタン医薬品APIの課題 - サルタン医薬品APIの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for API of Sartan Drugs estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for API of Sartan Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for API of Sartan Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for API of Sartan Drugs is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of API of Sartan Drugs include Dr. Reddy’s Laboratories, Verdant Pharma Pvt Ltd, Anuh Pharma Ltd., Ningbo Menovo Pharmaceutical, Tianyu Pharmaceutical, Zhejiang Huahai Pharmaceutical, Changzhou Kony Pharmaceutical, Zhejiang Kinglyuan Pharmaceutical and Zhejiang Xinsaike Pharmaceutical, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the API of Sartan Drugs production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of API of Sartan Drugs by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the API of Sartan Drugs manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional API of Sartan Drugs market. Further, it explains the major drivers and regional dynamics of the global API of Sartan Drugs market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Dr. Reddy’s Laboratories
Verdant Pharma Pvt Ltd
Anuh Pharma Ltd.
Ningbo Menovo Pharmaceutical
Tianyu Pharmaceutical
Zhejiang Huahai Pharmaceutical
Changzhou Kony Pharmaceutical
Zhejiang Kinglyuan Pharmaceutical
Zhejiang Xinsaike Pharmaceutical
Rundu Pharma
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
API of Sartan Drugs Segment by Type
Losartan API
Valsartan API
Irbesartan API
Olmesartan API
Candesartan API
Telmisartan API
API of Sartan Drugs Segment by Application
Tablets
Capsules
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the API of Sartan Drugs production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the API of Sartan Drugs market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for API of Sartan Drugs, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of API of Sartan Drugs, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for API of Sartan Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the API of Sartan Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global API of Sartan Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for API of Sartan Drugs sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Dr. Reddy’s Laboratories, Verdant Pharma Pvt Ltd, Anuh Pharma Ltd., Ningbo Menovo Pharmaceutical, Tianyu Pharmaceutical, Zhejiang Huahai Pharmaceutical, Changzhou Kony Pharmaceutical, Zhejiang Kinglyuan Pharmaceutical and Zhejiang Xinsaike Pharmaceutical, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: API of Sartan Drugs capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of API of Sartan Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of API of Sartan Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, API of Sartan Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 API of Sartan Drugs Product Introduction
1.2 Market by Type
1.2.1 Global API of Sartan Drugs Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Losartan API
1.2.3 Valsartan API
1.2.4 Irbesartan API
1.2.5 Olmesartan API
1.2.6 Candesartan API
1.2.7 Telmisartan API
1.3 Market by Application
1.3.1 Global API of Sartan Drugs Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Capsules
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global API of Sartan Drugs Production
2.1 Global API of Sartan Drugs Production Capacity (2017-2028)
2.2 Global API of Sartan Drugs Production by Region: 2017 VS 2021 VS 2028
2.3 Global API of Sartan Drugs Production by Region
2.3.1 Global API of Sartan Drugs Historic Production by Region (2017-2022)
2.3.2 Global API of Sartan Drugs Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
2.8 India
3 Global API of Sartan Drugs Sales in Volume & Value Estimates and Forecasts
3.1 Global API of Sartan Drugs Sales Estimates and Forecasts 2017-2028
3.2 Global API of Sartan Drugs Revenue Estimates and Forecasts 2017-2028
3.3 Global API of Sartan Drugs Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global API of Sartan Drugs Sales by Region
3.4.1 Global API of Sartan Drugs Sales by Region (2017-2022)
3.4.2 Global Sales API of Sartan Drugs by Region (2023-2028)
3.5 Global API of Sartan Drugs Revenue by Region
3.5.1 Global API of Sartan Drugs Revenue by Region (2017-2022)
3.5.2 Global API of Sartan Drugs Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global API of Sartan Drugs Production Capacity by Manufacturers
4.2 Global API of Sartan Drugs Sales by Manufacturers
4.2.1 Global API of Sartan Drugs Sales by Manufacturers (2017-2022)
4.2.2 Global API of Sartan Drugs Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of API of Sartan Drugs in 2021
4.3 Global API of Sartan Drugs Revenue by Manufacturers
4.3.1 Global API of Sartan Drugs Revenue by Manufacturers (2017-2022)
4.3.2 Global API of Sartan Drugs Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by API of Sartan Drugs Revenue in 2021
4.4 Global API of Sartan Drugs Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global API of Sartan Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global API of Sartan Drugs Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global API of Sartan Drugs Sales by Type
5.1.1 Global API of Sartan Drugs Historical Sales by Type (2017-2022)
5.1.2 Global API of Sartan Drugs Forecasted Sales by Type (2023-2028)
5.1.3 Global API of Sartan Drugs Sales Market Share by Type (2017-2028)
5.2 Global API of Sartan Drugs Revenue by Type
5.2.1 Global API of Sartan Drugs Historical Revenue by Type (2017-2022)
5.2.2 Global API of Sartan Drugs Forecasted Revenue by Type (2023-2028)
5.2.3 Global API of Sartan Drugs Revenue Market Share by Type (2017-2028)
5.3 Global API of Sartan Drugs Price by Type
5.3.1 Global API of Sartan Drugs Price by Type (2017-2022)
5.3.2 Global API of Sartan Drugs Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global API of Sartan Drugs Sales by Application
6.1.1 Global API of Sartan Drugs Historical Sales by Application (2017-2022)
6.1.2 Global API of Sartan Drugs Forecasted Sales by Application (2023-2028)
6.1.3 Global API of Sartan Drugs Sales Market Share by Application (2017-2028)
6.2 Global API of Sartan Drugs Revenue by Application
6.2.1 Global API of Sartan Drugs Historical Revenue by Application (2017-2022)
6.2.2 Global API of Sartan Drugs Forecasted Revenue by Application (2023-2028)
6.2.3 Global API of Sartan Drugs Revenue Market Share by Application (2017-2028)
6.3 Global API of Sartan Drugs Price by Application
6.3.1 Global API of Sartan Drugs Price by Application (2017-2022)
6.3.2 Global API of Sartan Drugs Price Forecast by Application (2023-2028)
7 North America
7.1 North America API of Sartan Drugs Market Size by Type
7.1.1 North America API of Sartan Drugs Sales by Type (2017-2028)
7.1.2 North America API of Sartan Drugs Revenue by Type (2017-2028)
7.2 North America API of Sartan Drugs Market Size by Application
7.2.1 North America API of Sartan Drugs Sales by Application (2017-2028)
7.2.2 North America API of Sartan Drugs Revenue by Application (2017-2028)
7.3 North America API of Sartan Drugs Sales by Country
7.3.1 North America API of Sartan Drugs Sales by Country (2017-2028)
7.3.2 North America API of Sartan Drugs Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe API of Sartan Drugs Market Size by Type
8.1.1 Europe API of Sartan Drugs Sales by Type (2017-2028)
8.1.2 Europe API of Sartan Drugs Revenue by Type (2017-2028)
8.2 Europe API of Sartan Drugs Market Size by Application
8.2.1 Europe API of Sartan Drugs Sales by Application (2017-2028)
8.2.2 Europe API of Sartan Drugs Revenue by Application (2017-2028)
8.3 Europe API of Sartan Drugs Sales by Country
8.3.1 Europe API of Sartan Drugs Sales by Country (2017-2028)
8.3.2 Europe API of Sartan Drugs Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific API of Sartan Drugs Market Size by Type
9.1.1 Asia Pacific API of Sartan Drugs Sales by Type (2017-2028)
9.1.2 Asia Pacific API of Sartan Drugs Revenue by Type (2017-2028)
9.2 Asia Pacific API of Sartan Drugs Market Size by Application
9.2.1 Asia Pacific API of Sartan Drugs Sales by Application (2017-2028)
9.2.2 Asia Pacific API of Sartan Drugs Revenue by Application (2017-2028)
9.3 Asia Pacific API of Sartan Drugs Sales by Region
9.3.1 Asia Pacific API of Sartan Drugs Sales by Region (2017-2028)
9.3.2 Asia Pacific API of Sartan Drugs Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America API of Sartan Drugs Market Size by Type
10.1.1 Latin America API of Sartan Drugs Sales by Type (2017-2028)
10.1.2 Latin America API of Sartan Drugs Revenue by Type (2017-2028)
10.2 Latin America API of Sartan Drugs Market Size by Application
10.2.1 Latin America API of Sartan Drugs Sales by Application (2017-2028)
10.2.2 Latin America API of Sartan Drugs Revenue by Application (2017-2028)
10.3 Latin America API of Sartan Drugs Sales by Country
10.3.1 Latin America API of Sartan Drugs Sales by Country (2017-2028)
10.3.2 Latin America API of Sartan Drugs Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa API of Sartan Drugs Market Size by Type
11.1.1 Middle East and Africa API of Sartan Drugs Sales by Type (2017-2028)
11.1.2 Middle East and Africa API of Sartan Drugs Revenue by Type (2017-2028)
11.2 Middle East and Africa API of Sartan Drugs Market Size by Application
11.2.1 Middle East and Africa API of Sartan Drugs Sales by Application (2017-2028)
11.2.2 Middle East and Africa API of Sartan Drugs Revenue by Application (2017-2028)
11.3 Middle East and Africa API of Sartan Drugs Sales by Country
11.3.1 Middle East and Africa API of Sartan Drugs Sales by Country (2017-2028)
11.3.2 Middle East and Africa API of Sartan Drugs Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Dr. Reddy’s Laboratories
12.1.1 Dr. Reddy’s Laboratories Corporation Information
12.1.2 Dr. Reddy’s Laboratories Overview
12.1.3 Dr. Reddy’s Laboratories API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Dr. Reddy’s Laboratories API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Dr. Reddy’s Laboratories Recent Developments
12.2 Verdant Pharma Pvt Ltd
12.2.1 Verdant Pharma Pvt Ltd Corporation Information
12.2.2 Verdant Pharma Pvt Ltd Overview
12.2.3 Verdant Pharma Pvt Ltd API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Verdant Pharma Pvt Ltd API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Verdant Pharma Pvt Ltd Recent Developments
12.3 Anuh Pharma Ltd.
12.3.1 Anuh Pharma Ltd. Corporation Information
12.3.2 Anuh Pharma Ltd. Overview
12.3.3 Anuh Pharma Ltd. API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Anuh Pharma Ltd. API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Anuh Pharma Ltd. Recent Developments
12.4 Ningbo Menovo Pharmaceutical
12.4.1 Ningbo Menovo Pharmaceutical Corporation Information
12.4.2 Ningbo Menovo Pharmaceutical Overview
12.4.3 Ningbo Menovo Pharmaceutical API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Ningbo Menovo Pharmaceutical API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Ningbo Menovo Pharmaceutical Recent Developments
12.5 Tianyu Pharmaceutical
12.5.1 Tianyu Pharmaceutical Corporation Information
12.5.2 Tianyu Pharmaceutical Overview
12.5.3 Tianyu Pharmaceutical API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Tianyu Pharmaceutical API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Tianyu Pharmaceutical Recent Developments
12.6 Zhejiang Huahai Pharmaceutical
12.6.1 Zhejiang Huahai Pharmaceutical Corporation Information
12.6.2 Zhejiang Huahai Pharmaceutical Overview
12.6.3 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Zhejiang Huahai Pharmaceutical API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Zhejiang Huahai Pharmaceutical Recent Developments
12.7 Changzhou Kony Pharmaceutical
12.7.1 Changzhou Kony Pharmaceutical Corporation Information
12.7.2 Changzhou Kony Pharmaceutical Overview
12.7.3 Changzhou Kony Pharmaceutical API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Changzhou Kony Pharmaceutical API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Changzhou Kony Pharmaceutical Recent Developments
12.8 Zhejiang Kinglyuan Pharmaceutical
12.8.1 Zhejiang Kinglyuan Pharmaceutical Corporation Information
12.8.2 Zhejiang Kinglyuan Pharmaceutical Overview
12.8.3 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Zhejiang Kinglyuan Pharmaceutical API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Zhejiang Kinglyuan Pharmaceutical Recent Developments
12.9 Zhejiang Xinsaike Pharmaceutical
12.9.1 Zhejiang Xinsaike Pharmaceutical Corporation Information
12.9.2 Zhejiang Xinsaike Pharmaceutical Overview
12.9.3 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Zhejiang Xinsaike Pharmaceutical API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Zhejiang Xinsaike Pharmaceutical Recent Developments
12.10 Rundu Pharma
12.10.1 Rundu Pharma Corporation Information
12.10.2 Rundu Pharma Overview
12.10.3 Rundu Pharma API of Sartan Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Rundu Pharma API of Sartan Drugs Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Rundu Pharma Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 API of Sartan Drugs Industry Chain Analysis
13.2 API of Sartan Drugs Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 API of Sartan Drugs Production Mode & Process
13.4 API of Sartan Drugs Sales and Marketing
13.4.1 API of Sartan Drugs Sales Channels
13.4.2 API of Sartan Drugs Distributors
13.5 API of Sartan Drugs Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 API of Sartan Drugs Industry Trends
14.2 API of Sartan Drugs Market Drivers
14.3 API of Sartan Drugs Market Challenges
14.4 API of Sartan Drugs Market Restraints
15 Key Finding in The Global API of Sartan Drugs Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer